Form 8-K - Current report:
SEC Accession No. 0000882095-21-000005
Filing Date
2021-02-04
Accepted
2021-02-04 16:05:01
Documents
16
Period of Report
2021-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20210204.htm   iXBRL 8-K 39977
2 EXHIBIT 99.1 exhibit991earningspressrel.htm EX-99.1 822868
8 GRAPHIC image0a091.jpg GRAPHIC 43356
  Complete submission text file 0000882095-21-000005.txt   1114684

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20210204.xsd EX-101.SCH 2417
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20210204_cal.xml EX-101.CAL 706
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20210204_def.xml EX-101.DEF 1639
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20210204_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20210204_pre.xml EX-101.PRE 12642
9 EXTRACTED XBRL INSTANCE DOCUMENT gild-20210204_htm.xml XML 10523
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 21591117
SIC: 2836 Biological Products, (No Diagnostic Substances)